52803-61-9

Basic information

• Product Name: Benzaldehyde, 3-methyl-2-(phenylmethoxy)-
• Synonyms: Benzaldehyde,3-methyl-2-(phenylmethoxy)
• CAS NO: 52803-61-9
• Molecular Formula: C15H14O2
• Molecular Weight: 226.275
• Mol File: 52803-61-9.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 3-methyl-2-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 3-methyl-2-(phenylmethoxy)-(52803-61-9)
• EPA Substance Registry System: Benzaldehyde, 3-methyl-2-(phenylmethoxy)-(52803-61-9)

Safety Data

• Hazardous Substances Data: 52803-61-9(Hazardous Substances Data)

Upstream product

• 188851-95-8 (2-(benzyloxy)-3-methylphenyl)methanol 
• 424791-13-9 methyl 2-(benzyloxy)-3-methylbenzoate 
• 83-40-9 3-methylsalicylic acid 
• 23287-26-5 3-methylsalicylic acid methyl ester 
• 824-42-0 2-methoxy-3-methylbenzaldehyde 
• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 

Downstream Products

• 27992-74-1 2-(4-methoxybenzyl)-6-methylphenol 
• 1453172-79-6 4-(benzyloxy)-5-methyl-2-methylisoindolin-1-one 
• 1453172-77-4 1-(2-(benzyloxy)-3-methylphenyl)-N-methylmethanamine 
• 188851-95-8 (2-(benzyloxy)-3-methylphenyl)methanol 
• 1335103-16-6 C₄₅H₄₅NO₃ 
• 1335103-13-3 (R)-bis(2-hydroxy-3-methylbenzyl)-[1-(2-hydroxyphenyl)ethyl]amine 
• 1335103-11-1 2-(benzyloxy)-1-(bromomethyl)-3-methylbenzene 
• 1221065-03-7 dimethyl 2-(2-(benzyloxy)-3-methylbenzylidene)malonate 
• 875109-60-7 (2-Benzyloxy-3-methylphenyl)-(4-methoxyphenyl)methanol 
• 111637-27-5 tri-(2-hydroxy-3-methylbenzyl)amine 
• 882533-07-5 tris-(2-benzyloxy-3-methyl-benzyl)-amine 

Relevant articles and documents

Synthesis and structure–activity relationships of aristoyagonine derivatives as brd4 bromodomain inhibitors with x-ray co-crystal research

Epigenetic regulation is known to play a key role in progression of anti-cancer therapeutics. Lysine acetylation is an important mechanism in controlling gene expression. There has been increasing interest in bromodomain owing to its ability to modulate t

TETRAHYDROISOQUINOLIN-2-YL-(QUINAZOLIN-4-YL) METHANONE COMPOUNDS AS CANCER CELL GROWTH INHIBITORS

Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone derivatives represented by formula (I), pharmacologically acceptable salts thereof, and compositions containing such compounds are described. Methods for treating hyperproliferative disorders by administering the compounds are also described. 1,2,3,4-tetrahydroisoquinoline derivatives for making tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds are also described.

Expeditious synthesis of benzopyrans via lewis acid-catalyzed C-H functionalization: Remarkable enhancement of reactivity by an ortho substituent

An expeditious construction of a benzopyran skeleton via Lewis acid-catalyzed C-H functionalization was achieved. In this process, a [1,5] hydride shift and 6-endo cyclization successively occurred to give benzopyrans. The presence of substituents ortho to the alkoxy group significantly enhanced the reactivity, affording the desired compounds in excellent chemical yields with short reaction times.